NLM Logo

FBM protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
FBM protocol
Unique ID
C417973
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C417973
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Carmustine
Melphalan
Vidarabine / *analogs & derivatives
Frequency
1
Note
chemotherapy protocol consisting of fludarabine (vidarabine/AA), carmustine & melphalan; used for reduced conditioning for rapid achievement of complete donor chimerism and low regimen-related toxicity after llogeneic transplantation
Source
Bone Marrow Transplant. 2000 Aug;26(3):243-50
Date of Entry
2001/01/10
Revision Date
2013/11/06
FBM protocol Preferred
page delivered in 0.005s